Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Cellectis S.A. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +2 vs. Q1 2023
- Shares held
- 14.0M
- −1.19M (−7.8%) vs. Q1 2023
- Total value
- $27.6M
- −$1.70M (−5.8%) vs. Q1 2023
- New holders
- 7
- 3 more added
- Sold out
- 5
- 11 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 31 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 56 | $0 | 0.00% | −9−13.8% | Reduced |
| Ronald Blue Trust, Inc. | 48 | $0 | 0.00% | +48 | New |
| Sofos Investments, Inc. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2 | $4 | 0.00% | −9,153−100.0% | Reduced |
| EverSource Wealth Advisors, LLC | 13 | $26 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 28 | $55 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 45 | $89 | 0.00% | +45 | New |
| Russell Investments Group, Ltd. | 98 | $193 | 0.00% | +98 | New |
| TD Waterhouse Canada Inc. | 360 | $702 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 500 | $984 | 0.00% | +500 | New |
| JPMorgan Chase & Co | 519 | $1.02K | 0.00% | −822−61.3% | Reduced |
| BNP Paribas Arbitrage, SA | 1,217 | $2.39K | 0.00% | +1,217 | New |
| Assetmark, Inc | 2,721 | $5.35K | 0.00% | +810+42.4% | Added |
| BlackRock Inc. | 2,755 | $5.42K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,970 | $5.85K | 0.00% | +2,970 | New |
| National Bank of Canada | 3,600 | $7.01K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 5,365 | $10.6K | 0.00% | −845−13.6% | Reduced |
| Geode Capital Management, LLC | 10,776 | $21.2K | 0.00% | 00.0% | Unchanged |
| One68 Global Capital, LLC | 11,000 | $21.6K | 0.13% | 00.0% | Unchanged |
| LPL Financial LLC | 14,007 | $27.6K | 0.00% | +1,650+13.4% | Added |
| Wells Fargo & Company | 15,919 | $31.3K | 0.00% | −560−3.4% | Reduced |
| Envestnet Asset Management Inc | 27,841 | $54.8K | 0.00% | −15,027−35.1% | Reduced |
| Citadel Advisors LLC | 29,983 | $59.1K | 0.00% | +29,983 | New |
| Morgan Stanley | 77,152 | $151.8K | 0.00% | −550−0.7% | Reduced |
| D. E. Shaw & Co., Inc. | 78,829 | $155.3K | 0.00% | −43,701−35.7% | Reduced |
| Oppenheimer & Co Inc | 117,689 | $231.6K | 0.00% | +1,526+1.3% | Added |
| KBC Group NV | 163,447 | $322.0K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 226,875 | $447.0K | 0.00% | 00.0% | Unchanged |
| Principal Financial Group Inc | 667,041 | $1.31M | 0.00% | −694,819−51.0% | Reduced |
| Millennium Management LLC | 1,167,641 | $2.30M | 0.00% | −12,418−1.1% | Reduced |
| Baillie Gifford & Co | 1,418,996 | $2.80M | 0.00% | −220,900−13.5% | Reduced |
| Credit Suisse AG | 1,438,255 | $2.83M | 0.00% | 00.0% | Unchanged |
| Capital International Investors | 1,848,804 | $3.64M | 0.00% | 00.0% | Unchanged |
| Bpifrance SA | 2,186,960 | $4.30M | 0.12% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 4,487,293 | $8.84M | 1.34% | 00.0% | Unchanged |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −129,434−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −50,522−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −22,329−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −330−100.0% | Sold out |